IGF1 and renal carcinoma: Studies reported that it promoted the development of pancreatic cancer, renal cancer, and oral cancer by mediating the IGF1 and AKT signaling pathways (Gao et al., 2014; Ma et al., 2015; Stoeltzing et al., 2007).